Literature DB >> 27780757

Heterologous expression of the human Phosphoenol Pyruvate Carboxykinase (hPEPCK-M) improves hydrogen and ethanol synthesis in the Escherichia coli dcuD mutant when grown in a glycerol-based medium.

Antonio Valle1, Gema Cabrera2, Domingo Cantero2, Jorge Bolivar3.   

Abstract

The production of biodiesel has emerged as an alternative to fossil fuels. However, this industry generates glycerol as a by-product in such large quantities that it has become an environmental problem. The biotransformation of this excess glycerol into other renewable bio-energy sources, like H2 and ethanol, by microorganisms such as Escherichia coli is an interesting possibility that warrants investigation. In this work we hypothesized that the conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP) could be improved by a controlled expression of the human mitochondrial GTP-dependent PEP carboxykinase. This heterologous expression was tested in several E. coli mutant backgrounds with increased availability of C4 intermediates. It was found that this metabolic rewiring improved the synthesis of the target products in several mutants, with the dcuD mutant being the most suitable background for hydrogen and ethanol specific productions and glycerol consumption. These factors increased by 2.46, 1.73 and 1.95 times, respectively, when compared to those obtained for the wild-type strain.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ethanol; Glycerol fermentation; Hydrogen; hPEPCK-M

Mesh:

Substances:

Year:  2016        PMID: 27780757     DOI: 10.1016/j.nbt.2016.10.007

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  1 in total

1.  Identification of Enzymatic Bottlenecks for the Aerobic Production of Malate from Glycerol by the Systematic Gene Overexpression of Anaplerotic Enzymes in Escherichia coli.

Authors:  Zamira E Soto-Varela; Gema Cabrera; Agustin Romero; Domingo Cantero; Antonio Valle; Jorge Bolivar
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.